The Role of Radiation Therapy and Stereotactic Radiosurgery in the Treatment of Pituitary Adenomas

ABSTRACT

Pituitary tumors can be managed with medication, surgical resection, radiation therapy (XRT), and stereotactic radiosurgery. Radiation approaches are best suited for patients with residual tumors after prior resection, particularly when the tumor involves the cavernous sinus. Irradiation can also be useful for patients with persistent hormone-secreting tumors despite resection or in those for whom resection would be associated with excessive risk. In this report, we review the rationale behind the various radiation approaches and discuss the risks and benefits of radiosurgery and XRT.

KEYWORDS

Pituitary tumor - radiosurgery - radiation therapy - acromegaly - Cushing's disease

REFERENCES

• 1 Sheline G E, Goldberg M B, Feldman R. Pituitary irradiation for acromegaly.  Radiology . 1961;  76 70-82
• 2 Sheline G E, Tyrell J B. Pituitary adenomas. In: Phillips TC, Pistenma DA, eds. Radiation Oncology Annual New York: Raven Press 1983
• 3 Cohen A R, Cooper P R, Kupersmith M J. Visual recovery after transsphenoidal removal of pituitary adenomas.  Neurosurgery . 1985;  17 446-452
• 4 Rush S, Kupersmith M J, Leuch I. Neuroophthalmologic assessment of vision before and after radiation therapy alone for pituitary macroadenomas.  J Neurosurg . 1990;  72 594-599
• 5 Degerblad M, Rahn T, Bergstrand G. Long-term results of stereotactic radiosurgery to pituitary gland in Cushing's disease.  Acta Endocrinologica . 1986;  112 310-314
• 6 Ganz J C, Backlund E O, Thorsen F A. The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies.  Stereotact Funct Neurosurg . 1993;  30-37
• 7 Pollock B E, Kondziolka D, Lunsford L D, Flickinger J C. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results.  Acta Neurochir . 1994;  62(suppl) 5-10
• 8 Rahn T, Thoren M, Werner S. Stereotactic radiosurgery in pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research New York: Excerpta Medica 1991: 303-312
• 9 Witt T, Kondziolka D, Flickinger J. Stereotactic radiosurgery for pituitary tumors.  Radiosurgery . 1996;  1 55-65
• 10 Duma C M, Lunsford L D, Kondziolka D, Harsh G R, Flickinger J C. Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery.  Neurosurgery . 1993;  32 699-705
• 11 Kondziolka D, Lunsford L D, Flickinger J C. Current concepts in gamma knife radiosurgery.  Neurosurg Quarterly . 1993;  3 253-271
• 12 Flickinger J C, Deutsch M, Lunsford L D. Repeat megavoltage irradiation of pituitary and suprasellar tumors.  Int J Radiat Oncol Biol Phys . 1989;  17 717-175
• 13 Flickinger J C, Nelson P B, Martinez A J. Radiotherapy of nonfunctional adenomas of the pituitary gland.  Cancer . 1989;  63 2409-2413
• 14 Brada M, Rajan B, Traish D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.  Clin Endocrinol . 1993;  38 571-578
• 15 Ludecke D K, Lutz B S, Niedwovok G. The choice of treatment in incomplete adenomectomy in acromegaly: proton versus high voltage radiation.  Acta Neurochir . 1989;  96 32-38
• 16 Rush S C, Newall J. Pituitary adenoma: the efficacy of radiotherapy as the sole treatment.  Int J Radiat Oncol Biol Phys . 1989;  17 165-169
• 17 Bowen J, Paulsen C A. Stroke after pituitary irradiation.  Stroke . 1992;  23 908-911
• 18 Flickinger J C, Kalend A. Use of normalized total dose to represent the biological effect of fractionated radiotherapy.  Radiother Oncol . 1990;  17 339-347
• 19 Flickinger J C, Lunsford L D, Singer J, Cano E R, Deutsch M. Megavoltage external beam irradiation of craniopharyngiomas: analysis of tumor control and morbidity.  Int J Radiat Oncol Biol Phys . 1990;  19 117-122
• 20 Flickinger J C, Nelson P B, Taylor F H. Incidence of cerebral infarction after radiotherapy for pituitary adenoma.  Cancer . 1989;  63 2404-2408
• 21 Grattan-Smith P J, Morris J G, Langlands A O. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumors.  J Neurol Neurosurg Psychiatry . 1992;  55 949-955
• 22 Littley M D, Shalet S M, Beardwell C G, Ahmed S R, Applegate G, Sutton M L. Hypopituitarism following external radiotherapy for pituitary tumors in adults.  Q J Med . 1989;  70(262) 145-160
• 23 Sheline G, Wara W, Smith V. Therapeutic irradiation and brain injury.  Int J Radiat Oncol Biol Phys . 1980;  6 1215-1228
• 24 Wigg D R, Murray M L, Koschel K. Tolerance of the central nervous system to photon irradiation: endocrine complications.  Acta Radiol Oncol 21 Fasc . 1982;  1 49-60
• 25 Barrow D L, Tindall G T, Kovacs K. Clinical and pathologic effects of bromocriptine on prolactin-secreting and other pituitary tumors.  J Neurosurgery . 1984;  60 1-7
• 26 Molitch M E, Celton R L, Blackwell R E. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.  J Clin Endocrinol Metabol . 1985;  60 698-705
• 27 Mehta A E, Reyes F L, Faihnern C. Primary radiotherapy of prolactinomas.  Am J Med . 1989;  83 59-68
• 28 Rush S, Donahue B, Cooper P. Prolactin reduction after combined modality therapy for prolactin macroadenomas.  Neurosurg . 1991;  28 502-505
• 29 Trampe E A, Lundell G, Lax I, Werner S. External irradiation of growth hormone producing pituitary adenomas: prolactin as a marker of hypothalamic and pituitary effects.  Int J Radiat Oncol Biol Phys . 1991;  20 655-660
• 30 Tsagarakis S, Grossman A, Plowman P N. Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.  Clin Endocrinol . 1991;  34 399-406
• 31 Tsang R W, Brierley J, Panzarella T. Role of radiation therapy in clinical hormonally active pituitary adenomas.  Radiother Oncol . 1996;  41 45-53
• 32 Caruso M, Shaw E, Davis D. Radiation treatment of growth hormone-secreting pituitary adenomas.  Int J Radiat Oncol Biol Phys . 1993;  21 121-122
• 33 Tran L M, Blount L, Horton D. Radiation therapy of pituitary tumors: results in 95 cases.  Am J Clin Oncol . 1991;  14 25-29
• 34 Werner S, Trampe E, Palacios P. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.  Int J Radiat Oncol Biol Phys . 1985;  11 1713-1720
• 35 Eastman R C, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly.  J Clin Endocrin Metab . 1979;  48 931-940
• 36 Schoenthaler R, Albright N W, Wara W M. Re-irradiation of pituitary adenoma.  Int J Radiat Oncol Biol Phys . 1992;  24 307-314
• 37 Sheline G E, Wara W M. Radiation therapy of acromegaly and nonsecretory chromophobe adenomas of the pituitary. In: Seydel HG, ed. Tumors of the Central Nervous System New York: John Wiley and Sons 1975: 119-131
• 38 Clarke S D, Woo S Y, Buther E B. Treatment of secretory pituitary adenoma with radiation therapy.  Radiology . 1993;  188 759-763
• 39 Doban F C, Raventos A, Boucot N. Roentgen therapy on Cushing syndrome without adrenocortical tumor.  J Clin Endocrinol Metab . 1957;  17 8
• 40 Edmonds M W, Simpson W J, Meakeh J W. External irradiation of the hypophysis for Cushing's disease.  Cal Med Assn J . 1972;  107 860
• 41 Grigsby P W, Simpson J R, Stokes S. Results of surgery and irradiation or irradiation alone for pituitary adenomas.  J Neurooncol . 1988;  6 129-134
• 42 Heuschele R, Lampe I. Pituitary irradiation for Cushing's syndrome.  N Engl J Med . 1967;  285 243
• 43 Estrada J, Boronat M, Mielgo M. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.  N Engl J Med . 1997;  336 172-177
• 44 McCollough W M, Marcus Jr B R, Rhoton Jr L A. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy.  Int J Radiat Oncol Biol Phys . 1991;  21 607-614
• 45 Nelson P B, Goodman M L, Flickinger J C. Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy.  Neurosurg . 1989;  24 398-400
• 46 Sheline G E. The role of conventional radiation therapy in the treatment of functional pituitary tumors. In: Linfoot JA, ed. Recent Advances in the Diagnosis and Treatment of Pituitary Tumors New York: Raven Press 1979: 289-313
• 47 Ciric I, Mikhael M, Stafford T. Transsphenoidal neurosurgery of pituitary macroadenomas with long-term follow-up results.  J Neurosurgery . 1983;  59 395-401
• 48 Laws Jr R E, Trautman J C, Hollenhorst Jr W R. Transsphenoidal decompression of the optic nerve and chiasm: visual results in 62 patients.  J Neurosurg . 1977;  46 717-722
• 49 Fisher B J, Gaspar L E, Noone B. Radiation therapy of pituitary adenoma: delayed sequelae.  Radiology . 1993;  187 843-846
• 50 Tsang R W, Laperriere N J, Simpson W J. Glioma arising after radiation therapy for pituitary adenoma: a report of four patients and estimation of risk.  Cancer . 1993;  72 2227-2233
• 51 Kjellberg R N, Kliman B. Lifetime effectiveness: a system of therapy for pituitary adenomas, emphasizing Bragg peak proton hypophysectomy. In: Linfoort JA, ed. Recent Advances in the Diagnosis and Treatment of Pituitary Tumors New York: Raven Press 1979: 269-288
• 52 Levy R P, Fabrikand J I, Frankel K A. Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients.  Stereotact Funct Neurosurg . 1991;  57 22-35
• 53 Backlund E O, Rahn T, Sarby D, de Schryver A, Wennnerstrand J. Closed stereotaxic hypophysectomy by means of 60-cobalt gamma radiation.  Acta Radiol Ther Phys Biol . 1972;  11 545-555
• 54 Flickinger J C, Lunsford L D, Wu A, Maitz A H, Kalend A M. Treatment planning for gamma knife radiosurgery with multiple isocenters.  Int J Radiat Oncol Biol Phys . 1989;  18 1495-1501
• 55 Flickinger J C, Maitz A, Kalend A, Lunsford L D, Wu A. Treatment volume shaping with selective beam blocking using the Leksell gamma unit.  Int J Radiat Oncol Biol Phys . 1990;  19 783-789
• 56 Flickinger J C, Lunsford L D, Kondziolka D. Dose prescription and dose-volume effects in radiosurgery.  Neurosurg Clin North Am . 1992;  3 51-59
• 57 Stephanian E, Lunsford L D, Coffey R J, Bissonette D J, Flickinger J C. Gamma knife surgery for sellar and suprasellar tumors.  Neurosurg Clin North Am . 1992;  3 207-218
• 58 Hoybye C, Grenblack E, Rahn T. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery.  Neurosurg . 2001;  49 284-292
• 59 Sheehan J M, Vance M L, Sheehan J P. Radiosurgery for Cushing's disease after failed transsphenoidal surgery.  J Neurosurg . 2000;  93 738-742
• 60 Landolt A M, Haller D, Lomax N. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.  J Neurosurg . 1998;  88 1002-1008
• 61 Landolt A M, Haller D, Lomax N. Octreotide may act as a radioprotective agent in acromegaly.  J Clin Endocrinol Metab . 2000;  85 1287-1289
• 62 Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone- secreting pituitary adenoma.  J Neurosurg . 2001;  95 285-291